Previously Recorded on June 17, 2020
This session presenters, Dianne Bourque and Benjamin Zegarelli from Mintz, will explore the widespread disruptions the crisis is posing to clinical trials for life sciences companies and to research study sites. They will also discuss recent guidance from regulatory authorities and practical steps f...
Previously Recorded on May 27, 2020
The following topics will be covered in this webinar: Outlining potential product liability risk involving COVID (defect claims involving marketing/advertising, warranties, and warnings) Tips on how to mitigate the risks of potential product liability claims involving COVID and how to defend them....
Previously Recorded on April 2, 2020
As the country responds to the COVID-19 pandemic, life sciences companies as well as manufacturers that do not normally produce medical devices are coming together to fill the vast gaps in availability of supplies of critical medical equipment. As a result, many manufacturers are grappling with qu...
Previously Recorded on March 31, 2020
As the country responds to the COVID-19 pandemic, life sciences companies as well as manufacturers that do not normally produce medical devices are coming together to fill the vast gaps in availability of supplies of critical medical equipment. As a result, many manufacturers are grappling with que...
Previously Recorded on March 25, 2020
Digital medical devices employ some form of computing hardware and/or software. However, this technology can carry complex and very costly cyber risks that arise during product development and after commercialization. Learn More...
Previously Recorded on January 29, 2020
A look at potential changes facing FDA-regulated life sciences industry in 2020
Previously Recorded on December 11, 2019
In this year’s annual year-end wrap up, a panel that includes Sonia Valdes, Medmarc’s Vice President of Claims, and members of Medmarc’s esteemed defense network will summarize the state of the medical device industry from the court of public opinion to the United States Supreme Court. The panel wil...
Previously Recorded on November 21, 2019
In this webinar, toxicologist Dr. Joel Cohen, and chemists Dr. Mark Jordi, and Dr. Jim Rice will discuss strategies for evaluating safety and biocompatibility of a device.
Previously Recorded on October 22, 2019
The life sciences landscape is constantly—and rapidly—evolving. Staying on top of news and trends is a challenge in such a dynamic environment.
Previously Recorded on September 18, 2019
Earlier this year, the Criminal Division of the U.S. Department of Justice (DOJ) issued updated guidance for white-collar prosecutors.
Previously Recorded on August 22, 2019
As medical devices become more connected and interactive with health care providers, fundamental security challenges are increasingly important.
Previously Recorded on July 24, 2019
3D printing has been a disruptive technology to the medical device industry, and its use and applications continue to grow.
Previously Recorded on June 27, 2019
In this webinar, seasoned attorneys Beth Rose and Paul Farquharson will look at recent litigation involving 510(k) products and processes.
Previously Recorded on April 24, 2019
The success (or failure) of a company is determined in large part by its products and how its technology differentiates those products from competitors’.
Previously Recorded on March 20, 2019
With the U.S. House and Senate divided along political lines, and the longest government shutdown, Congress has begun to lay out its healthcare agenda.
Previously Recorded on February 27, 2019
The evolution of MRI safety compatibility testing has necessitated the evaluation and in some instances re-evaluation of medical devices for MRI safety.
Previously Recorded on January 16, 2019
In this annual webinar, two attorneys in Medmarc’s Risk Management Department will break down some of the biggest headlines from the last year.
Previously Recorded on December 11, 2018
In this year's annual year-end wrap up, we will summarize the State of the Medical Device Industry, from the court of public opinion to the US Supreme Court.
Previously Recorded on November 16, 2018
Ethical conduct is critical in all business operations, but especially so in industries like life sciences, where health and safety are at stake.
Previously Recorded on September 19, 2018
For life science startups, two of the primary sources of non-dilutive funding are Grants and the Payroll/Startup Research & Development (R&D) Tax Credit.